Travere Therapeutics insider Jeffrey A. Meckler exercised Options for 20,000 shares on 2026-09-10 at $17.44 to $26.52 per share. Investors can see the resulting ownership positions after the related transactions: 91,500 shares remained, while derivative securities ownership fell to 0.

Key Highlights

  • Jeffrey A. Meckler sold 20,000 Travere Therapeutics shares across four transactions at $65.39 to $68.09 per share.
  • Meckler owned 111,500 shares after exercising the options and 91,500 shares after the sales.
  • The transactions left Meckler with 0 derivative securities.

Option Exercise and Share Sales

The exercise was divided across two transactions. The same date also included four transactions coded S, representing sales of 20,000 shares at prices ranging from $65.39 to $68.09 per share. Meckler’s exercise transactions covered 20,000 derivative securities at $0 per share. The transactions were reported for Jeffrey A. Meckler, an insider of Travere Therapeutics (NASDAQ: TVTX). The exercise prices and sale prices were disclosed separately for their respective transaction groups.

Ownership After the Transactions

Meckler owned 111,500 shares after the option exercises. His reported share ownership stood at 91,500 after the sales. The derivative securities position following the transactions was 0. The reported ownership figures show the share position after each transaction group. The option exercise and sale activity were both dated 10 September 2026.